Client News

Newron announces agreement with the European Investment Bank (EIB) to extend the near-term tranche repayment dates of its 2018 Finance Contract

AFYREN obtains ISO 9001 certification, a globally acknowledged standard of rigor and performance, for its AFYREN NEOXY plant

Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS

Formycon secures license date for aflibercept 2 mg biosimilar FYB203 in Europe and further territories following settlement with Regeneron and Bayer

InflaRx Announces Late-Breaker Oral Presentation on Vilobelimab Phase 3 Results in Pyoderma Gangrenosum at 2026 American Academy of Dermatology Annual Meeting

Darwin AG launches commercialization of Multi-Cancer Check—a blood test for early detection of 13 types of cancer

Newron announces nominations to its Board of Directors at upcoming Annual General Meeting

NVision and Aarhus University Awarded Innovation Fund Denmark Grant to Advance Clinical Translation of Quantum-Enhanced MRI

InflaRx Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

Galimedix Therapeutics earns milestone payment in ophthalmology partnership with Théa Open Innovation